Trial Profile
Study of the combination of gemcitabine, cetuximab and radiotherapy in patients with head and neck cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Gemcitabine (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- 25 Sep 2014 New trial record